<?xml version="1.0" encoding="UTF-8"?>
<p id="Par4">Antiviral drugs as well as a variety of other putative treatments are typically being prescribed for deteriorating patients on a compassionate basis. Clinicians would be well aware of such situations but assurance is required that their safety and efficacy are being scientifically assessed so that meaning is brought to bear quickly. Coordination of clinical trials to avoid duplication and ensure that results are rapidly available will be a challenge but the case numbers should facilitate rapid definitive results. (see 
 <xref rid="Sec6" ref-type="sec">What is in the pipeline for vaccine development and/or therapeutics?</xref>).
</p>
